Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bezafibrate for cholestatic itch
NL-OMON22138Phase 2Active, not recruiting
- Sponsor
- Amsterdam University Medical Center
- Start
- Mar 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised trial in cholestatic pruritus comparing Bezafibrate with Placebo (2 arms). Primary endpoint: Responder rate for itch reduction. Started Mar 2016; status: active, not recruiting.
02
Drugs
bezafibrate
03
Conditions
cholestatic pruritus
Beyond the preview
Go deeper on NL-OMON22138.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON22138.